Net profit of Trident Texofab rose 90.00% to Rs 0.57 crore in the quarter ended December 2025 as against Rs 0.30 crore during the previous quarter ended December 2024. Sales declined 18.78% to Rs 25.74 crore in the quarter ended December 2025 as against Rs 31.69 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales25.7431.69 -19 OPM %6.377.29 - PBDT1.250.68 84 PBT0.840.27 211 NP0.570.30 90 Powered by Capital Market - Live News

Trident Texofab will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live News

Net profit of Trident Texofab rose 13.00% to Rs 1.13 crore in the quarter ended September 2025 as against Rs 1.00 crore during the previous quarter ended September 2024. Sales rose 15.80% to Rs 30.63 crore in the quarter ended September 2025 as against Rs 26.45 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales30.6326.45 16 OPM %8.13-1.06 - PBDT1.921.35 42 PBT1.510.94 61 NP1.131.00 13 Powered by Capital Market - Live News

Trident Texofab will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Trident Texofab announced that the 17th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live News